Dow Up0.11% Nasdaq Up0.50%

Transcept Pharmaceuticals, Inc. (TSPT)

-NasdaqGM
2.20 Down 0.01(0.45%) Aug 29, 3:59PM EDT
|After Hours : 2.20 0.00 (0.00%) Aug 29, 4:01PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 362   418   316   468  
Cost of Revenue -   -  140  86  
Gross Profit 362   418   176   382  
Operating Expenses
Research Development585  708  1,753  2,410  
Selling General and Administrative3,079  2,496  3,941  2,658  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,302) (2,786) (5,518) (4,686)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes(3,326)(2,804)(5,535)(4,703)
Interest Expense -   -   -   -  
Income Before Tax(3,326)(2,804)(5,535)(4,703)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,326)(2,804)(5,535)(4,703)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,326) (2,804) (5,535) (4,703)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,326) (2,804) (5,535) (4,703)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.